2025

• Pinto C.M. et al. : Graves’ Disease : Autoimmune Disease Diagnosis Systemic and Organ Specific Diseases Second Edition . Pags. 355-360 (2025).
  DOI: 10.1007/978-3-031-69895-8_49
  Citas: 0
• Mendoza C.A. et al. : Postpartum Thyroiditis : Autoimmune Disease Diagnosis Systemic and Organ Specific Diseases Second Edition . Pags. 361-365 (2025).
  DOI: 10.1007/978-3-031-69895-8_50
  Citas: 0
• Realpozo P.M. et al. : Subacute Thyroiditis : Autoimmune Disease Diagnosis Systemic and Organ Specific Diseases Second Edition . Pags. 351-354 (2025).
  DOI: 10.1007/978-3-031-69895-8_48
  Citas: 0
• García-Carrasco M. et al. : Pernicious Anemia : Autoimmune Disease Diagnosis Systemic and Organ Specific Diseases Second Edition . Pags. 705-709 (2025).
  DOI: 10.1007/978-3-031-69895-8_104
  Citas: 0
• García-Carrasco M. et al. : Raynaud’s Phenomenon (RP) : Autoimmune Disease Diagnosis Systemic and Organ Specific Diseases Second Edition . Pags. 67-73 (2025).
  DOI: 10.1007/978-3-031-69895-8_10
  Citas: 0
• Mendoza-Pinto C. et al. : Mortality Trends in Polymyositis and Dermatomyositis in Mexico: A General Population-Based Study from 2000 to 2019 : Journal of Clinical Rheumatology (2025).
  DOI: 10.1097/RHU.0000000000002211
  Citas: 0

2024

• Etchegaray-Morales I. et al. : Epidemiology of systemic lupus erythematosus in Latin America : Reumatologia Clinica 20 (10) . Pags. 560-566 (2024).
  DOI: 10.1016/j.reuma.2024.09.005
  Citas: 0
• Mendoza-Pinto C. et al. : Machine learning in the prediction of treatment response in rheumatoid arthritis: A systematic review : Seminars in Arthritis and Rheumatism 68 (2024).
  DOI: 10.1016/j.semarthrit.2024.152501
  Citas: 1
• Etchegaray-Morales I. et al. : Risk of diabetes mellitus in systemic lupus erythematosus: systematic review and meta-analysis : Rheumatology United Kingdom 63 (8) . Pags. 2047-2055 (2024).
  DOI: 10.1093/rheumatology/keae204
  Citas: 4
• Munguía-Realpozo P. et al. : Correction to: Trends in mortality in patients with systemic autoimmune rheumatic diseases (SARD) during the COVID-19 pandemic in Mexico (Rheumatology International, (2023), 43, 9, (1611-1619), 10.1007/s00296-023-05371-w) : Rheumatology International 44 (8) . Pags. 1585-1586 (2024).
  DOI: 10.1007/s00296-024-05625-1
  Citas: 0
• Munguía-Realpozo P. et al. : Non-invasive imaging in antiphospholipid syndrome to assess subclinical coronary artery disease : Autoimmunity Reviews 23 (3) (2024).
  DOI: 10.1016/j.autrev.2023.103505
  Citas: 3
• Mendoza-Pinto C. et al. : Burden of Other Musculoskeletal Disorders in Latin America and the Caribbean: Findings of Global Burden of Disease Study 2019 : Journal of Clinical Rheumatology 30 (1) . Pags. 1-7 (2024).
  DOI: 10.1097/RHU.0000000000002034
  Citas: 5
• Mendoza-Pinto C. et al. : Trends in the disease burden of musculoskeletal disorders in Mexico from 1990–2019 : Clinical Rheumatology 43 (1) . Pags. 1-13 (2024).
  DOI: 10.1007/s10067-023-06775-6
  Citas: 2

2023

• Mendoza-Pinto C. et al. : SLICC-Frailty Index and Its Association with Low Bone Mineral Density and Vertebral Fractures in Women with Systemic Lupus Erythematosus : Calcified Tissue International 113 (5) . Pags. 475-480 (2023).
  DOI: 10.1007/s00223-023-01117-9
  Citas: 2
• Mendoza-Pinto C. et al. : Correction: SLICC-Frailty Index and Its Association with Low Bone Mineral Density and Vertebral Fractures in Women with Systemic Lupus Erythematosus (Calcified Tissue International, (2023), 113, 5, (475-480), 10.1007/s00223-023-01117-9) : Calcified Tissue International 113 (5) . Pags. 481-482 (2023).
  DOI: 10.1007/s00223-023-01136-6
  Citas: 0
• Mendoza-Pinto C. et al. : Low disease activity state associated with fewer incident vertebral fractures in Mestizo women with systemic lupus erythematosus : Lupus 32 (11) . Pags. 1328-1334 (2023).
  DOI: 10.1177/09612033231202878
  Citas: 0
• Munguía-Realpozo P. et al. : Trends in mortality in patients with systemic autoimmune rheumatic diseases (SARD) during the COVID-19 pandemic in Mexico : Rheumatology International 43 (9) . Pags. 1611-1619 (2023).
  DOI: 10.1007/s00296-023-05371-w
  Citas: 1
• Munguía-Realpozo P. et al. : Current state and completeness of reporting clinical prediction models using machine learning in systemic lupus erythematosus: A systematic review : Autoimmunity Reviews 22 (5) (2023).
  DOI: 10.1016/j.autrev.2023.103294
  Citas: 8
• Mendoza-Pinto C. et al. : Microorganisms in the Pathogenesis and Management of Anti-phospholipid Syndrome (Hughes Syndrome) : Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases Volume II Kidney Central Nervous System Eye Blood Blood Vessels and Bowel 2 . Pags. 341-357 (2023).
  DOI: 10.1007/978-981-19-4800-8_17
  Citas: 2
• Moreno-Salgado A. et al. : Alterations of the Ca2+ clearing mechanisms by type 2 diabetes in aortic smooth muscle cells of Zucker diabetic fatty rat : Frontiers in Physiology 14 (2023).
  DOI: 10.3389/fphys.2023.1200115
  Citas: 5
• García-Carrasco M. et al. : Insulin Resistance and Diabetes Mellitus in Patients with Systemic Lupus Erythematosus : Endocrine Metabolic and Immune Disorders Drug Targets 23 (4) . Pags. 503-514 (2023).
  DOI: 10.2174/1871530322666220908154253
  Citas: 13

2022

• Juárez-Melchor D. et al. : Genetic Component of Autoimmune Rheumatological Diseases : Reumatologia Clinica 18 (10) . Pags. 614-620 (2022).
  DOI: 10.1016/j.reuma.2021.08.003
  Citas: 2
• Mendoza-Pinto C. et al. : Trends in all-cause hospitalizations for systemic lupus erythematosus in Mexico, 2000–2019 : Lupus 31 (13) . Pags. 1679-1684 (2022).
  DOI: 10.1177/09612033221128745
  Citas: 1
• Munguía-Realpozo P. et al. : Higher body mass index and disease duration are associated with increased risk of left ventricular diastolic dysfunction in women with systemic lupus erythematosus : Lupus 31 (13) . Pags. 1639-1648 (2022).
  DOI: 10.1177/09612033221128433
  Citas: 0
• Etchegaray-Morales I. et al. : Systemic lupus erythematosus, a leading cause of death in young Mexican females: a nationwide population-based study, 2000–2020 : Rheumatology International 42 (10) . Pags. 1715-1720 (2022).
  DOI: 10.1007/s00296-022-05154-9
  Citas: 6
• Berra-Romani R. et al. : Histamine activates an intracellular Ca2+ signal in normal human lung fibroblast WI-38 cells : Frontiers in Cell and Developmental Biology 10 (2022).
  DOI: 10.3389/fcell.2022.991659
  Citas: 9
• Munguía-Realpozo P. et al. : Absence of association between nailfold capillary findings and mild cognitive dysfunction in systemic lupus erythematosus : Clinical Rheumatology 41 (9) . Pags. 2737-2743 (2022).
  DOI: 10.1007/s10067-022-06215-x
  Citas: 0
• García-Carrasco M. et al. : Temporal Trends in Mortality in Patients with Systemic Sclerosis in Public Hospitals Across Mexico from 1998–2017 : Archives of Medical Research 53 (6) . Pags. 610-616 (2022).
  DOI: 10.1016/j.arcmed.2022.07.005
  Citas: 3
• Munguía-Realpozo P. et al. : Metabolomic Profile of Insulin Resistance Women with Systemic Lupus Erythematosus : Hormone and Metabolic Research 55 (7) . Pags. 487-492 (2022).
  DOI: 10.1055/a-2093-0260
  Citas: 0
• Mendoza-Pinto C. et al. : Asymptomatic coronary artery disease assessed by coronary computed tomography in patients with systemic lupus erythematosus: A systematic review and meta-analysis : European Journal of Internal Medicine 100 . Pags. 102-109 (2022).
  DOI: 10.1016/j.ejim.2022.04.001
  Citas: 10
• Mendoza-Pinto C. et al. : Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: Results from a nationwide health registry : Lupus 31 (3) . Pags. 382-391 (2022).
  DOI: 10.1177/09612033221078228
  Citas: 11

2021

• Morales-Etchegaray I. et al. : Changing trends in rheumatoid arthritis mortality in Mexico, from 1998 to 2017 : Rheumatology International 41 (12) . Pags. 2225-2231 (2021).
  DOI: 10.1007/s00296-021-05013-z
  Citas: 2
• Mendoza-Pinto C. et al. : Insulin resistance metabolomic profile in non-diabetic women with systemic lupus erythematosus : Gaceta Medica De Mexico 157 (6) . Pags. 613-617 (2021).
  DOI: 10.24875/GMM.21000218
  Citas: 1
• Mendoza-Pinto C. et al. : Therapeutic Options for the Management of Severe COVID-19: A Rheumatology Perspective : Reumatologia Clinica 17 (8) . Pags. 431-436 (2021).
  DOI: 10.1016/j.reuma.2020.05.002
  Citas: 8
• Mendoza-Pinto C. et al. : A Retrospective Analysis of Longitudinal Changes in Bone Mineral Density in Women with Systemic Lupus Erythematosus : Calcified Tissue International 109 (4) . Pags. 363-371 (2021).
  DOI: 10.1007/s00223-021-00845-0
  Citas: 4
• Martínez-Ceballos M.A. et al. : Coronary calcium in autoimmune diseases: A systematic literature review and meta-analysis : Atherosclerosis 335 . Pags. 68-76 (2021).
  DOI: 10.1016/j.atherosclerosis.2021.09.017
  Citas: 14
• Munguía-Realpozo P. et al. : The impact of antimalarial agents on traditional and non-traditional subclinical atherosclerosis biomarkers in systemic lupus erythematosus: A systematic review and meta-analysis : Autoimmunity Reviews 20 (9) (2021).
  DOI: 10.1016/j.autrev.2021.102887
  Citas: 12
• Mendoza-Pinto C. et al. : Medication adherence is influenced by resilience in patients with systemic lupus erythematosus : Lupus 30 (7) . Pags. 1051-1057 (2021).
  DOI: 10.1177/09612033211004722
  Citas: 17
• Escobar-Soto C.H. et al. : Human mesenchymal stem cells for the management of systemic sclerosis. Systematic review : Autoimmunity Reviews 20 (6) (2021).
  DOI: 10.1016/j.autrev.2021.102831
  Citas: 12
• Etchegaray-Morales I. et al. : Helicobacter pylori and its association with autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis and Sjögren syndrome : Journal of Translational Autoimmunity 4 (2021).
  DOI: 10.1016/j.jtauto.2021.100135
  Citas: 12
• García-Carrasco M. et al. : The role of IgE in systemic lupus erythematosus : Autoimmunity Reviews 20 (1) (2021).
  DOI: 10.1016/j.autrev.2020.102704
  Citas: 5
• Mendoza-Pinto C. et al. : Perfil metabolómico de resistencia a la insulina en mujeres no diabéticas con lupus eritematoso sistémico : Gaceta Medica De Mexico 157 (6) . Pags. 594-598 (2021).
  DOI: 10.24875/GMM.M21000622
  Citas: 1

2020

• Mendoza-Pinto C. et al. : Viral infections and their relationship with catastrophic antiphospholipid syndrome: a possible pathogenic mechanism of severe COVID-19 thrombotic complications : Journal of Internal Medicine 288 (6) . Pags. 737-739 (2020).
  DOI: 10.1111/joim.13123
  Citas: 18
• Escárcega R.O. et al. : The Cardio-Rheumatology Approach to Atherosclerotic Cardiovascular Disease : Reumatologia Clinica 16 (5) . Pags. 311-312 (2020).
  DOI: 10.1016/j.reuma.2020.07.001
  Citas: 2
• Komici K. et al. : Systemic lupus erythematosus, endothelial progenitor cells and intracellular Ca2+ signaling: A novel approach for an old disease : Journal of Autoimmunity 112 (2020).
  DOI: 10.1016/j.jaut.2020.102486
  Citas: 14
• García-Carrasco M. et al. : Comparing cytology, colposcopy and human papillomavirus cervical intraepithelial lesion screening methods in women with systemic lupus erythematosus : Lupus 29 (9) . Pags. 1060-1066 (2020).
  DOI: 10.1177/0961203320931176
  Citas: 0
• Mendoza-Pinto C. et al. : Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: A systematic review and meta-analysis : Atherosclerosis 297 . Pags. 55-63 (2020).
  DOI: 10.1016/j.atherosclerosis.2020.01.028
  Citas: 39
• Mendoza-Pinto C. et al. : Helicobacter pylori infection and gastroduodenal lesions in patients with systemic lupus erythematosus : Clinical Rheumatology 39 (2) . Pags. 463-469 (2020).
  DOI: 10.1007/s10067-019-04805-w
  Citas: 8
• Berra-Romani R. et al. : Histamine induces intracellular Ca2+ oscillations and nitric oxide release in endothelial cells from brain microvascular circulation : Journal of Cellular Physiology 235 (2) . Pags. 1515-1530 (2020).
  DOI: 10.1002/jcp.29071
  Citas: 36
• Berra-Romani R. et al. : Type 2 diabetes alters intracellular Ca2+ handling in native endothelium of excised rat aorta : International Journal of Molecular Sciences 21 (1) (2020).
  DOI: 10.3390/ijms21010250
  Citas: 24

2019

• García-Carrasco M. et al. : Functional gastrointestinal disorders in women with systemic lupus erythematosus: A case-control study : Neurogastroenterology and Motility 31 (11) (2019).
  DOI: 10.1111/nmo.13693
  Citas: 5
• García-Carrasco M. et al. : 25-Hydroxyvitamin D concentrations and risk of metabolic syndrome in systemic lupus erythematosus women : International Journal of Rheumatic Diseases 22 (11) . Pags. 2067-2072 (2019).
  DOI: 10.1111/1756-185X.13715
  Citas: 4
• Munguia-Realpozo P. et al. : Systemic lupus erythematosus and hypertension : Autoimmunity Reviews 18 (10) (2019).
  DOI: 10.1016/j.autrev.2019.102371
  Citas: 62
• García-Carrasco M. et al. : Associations between resilience and sociodemographic factors and depressive symptoms in women with systemic lupus erythematosus : Journal of Psychosomatic Research 122 . Pags. 39-42 (2019).
  DOI: 10.1016/j.jpsychores.2019.05.002
  Citas: 8
• Gallego J.M.S. et al. : Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis : Rheumatology International 39 (5) . Pags. 841-849 (2019).
  DOI: 10.1007/s00296-019-04288-7
  Citas: 16
• Garcia-Carrasco M. et al. : Reply to the editor : Autoimmunity Reviews 18 (4) . Pags. 435-436 (2019).
  DOI: 10.1016/j.autrev.2019.02.007
  Citas: 0
• García-Carrasco M. et al. : Corrigendum to ‘Prevalence of cervical HPV infection in women with systemic lupus erythematosus: a systematic review and meta-analysis’. [AUTREV 18-2 (2019) 184–191](S1568997218302878)(10.1016/j.autrev.2018.09.001) : Autoimmunity Reviews 18 (4) . Pags. 437 (2019).
  DOI: 10.1016/j.autrev.2019.02.001
  Citas: 2
• García-Carrasco M. et al. : Prevalence of cervical HPV infection in women with systemic lupus erythematosus: A systematic review and meta-analysis : Autoimmunity Reviews 18 (2) . Pags. 184-191 (2019).
  DOI: 10.1016/j.autrev.2018.09.001
  Citas: 30

2018

• García-Carrasco M. et al. : The anti-thrombotic effects of vitamin D and their possible relationship with antiphospholipid syndrome : Lupus 27 (14) . Pags. 2181-2189 (2018).
  DOI: 10.1177/0961203318801520
  Citas: 22
• Mendoza-Pinto C. et al. : Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant) : Current Rheumatology Reports 20 (10) (2018).
  DOI: 10.1007/s11926-018-0773-x
  Citas: 76
• Vazquez-De-Lara L.G. et al. : Phosphatidylethanolamine induces an antifibrotic phenotype in normal human lung fibroblasts and ameliorates bleomycin-induced lung fibrosis in mice : International Journal of Molecular Sciences 19 (9) (2018).
  DOI: 10.3390/ijms19092758
  Citas: 23
• Méndez-Martínez S. et al. : Factors of the epidemiological triad that influence the persistence of human papilloma virus infection in women with systemic lupus erythematosus : Lupus 27 (9) . Pags. 1542-1546 (2018).
  DOI: 10.1177/0961203318773176
  Citas: 12
• Escárcega R. et al. : Inflammation and atherosclerosis: Cardiovascular evaluation in patients with autoimmune diseases : Autoimmunity Reviews 17 (7) . Pags. 703-708 (2018).
  DOI: 10.1016/j.autrev.2018.01.021
  Citas: 78
• García-Carrasco M. et al. : Prevalence of functional gastrointestinal disorders in adults with systemic lupus erythematosus : Lupus 27 (5) . Pags. 788-793 (2018).
  DOI: 10.1177/0961203317747718
  Citas: 7
• Mendoza Pinto C. et al. : GRADE system, systematic and transparent evaluation : Reumatologia Clinica 14 (2) . Pags. 65-67 (2018).
  DOI: 10.1016/j.reuma.2017.07.010
  Citas: 7
• García-Carrasco M. et al. : The role of circulating regulatory T cell levels on subclinical atherosclerosis and cardiovascular risk factors in women with systemic lupus erythematosus : Mediators of Inflammation 2018 (2018).
  DOI: 10.1155/2018/3271572
  Citas: 10
• Jakez-Ocampo J. et al. : Vß T cell receptor (TCR) genes in circulating cells of patients with systemic lupus erythematosus and their healthy relatives : Gaceta Medica De Mexico 154 (1) . Pags. 74-79 (2018).
  DOI: 10.24875/GMM.17002697
  Citas: 4

2017

• García-Carrasco M. et al. : Clinical relevance of P-glycoprotein activity on peripheral blood mononuclear cells and polymorphonuclear neutrophils to methotrexate in systemic lupus erythematosus patients : Clinical Rheumatology 36 (10) . Pags. 2267-2272 (2017).
  DOI: 10.1007/s10067-017-3728-0
  Citas: 6
• García-Carrasco M. et al. : Incidence of Vertebral Fractures in Women with Systemic Lupus Erythematosus After 8 Years of Follow-Up : Calcified Tissue International 101 (3) . Pags. 291-299 (2017).
  DOI: 10.1007/s00223-017-0286-z
  Citas: 10
• Mendoza-Pinto C. et al. : Incidence of cervical human papillomavirus infection in systemic lupus erythematosus women : Lupus 26 (9) . Pags. 944-951 (2017).
  DOI: 10.1177/0961203316686708
  Citas: 19
• Méndez-Martínez S. et al. : Genital Mycoplasma infection among Mexican women with systemic lupus erythematosus : International Journal of Gynecology and Obstetrics 138 (1) . Pags. 17-22 (2017).
  DOI: 10.1002/ijgo.12154
  Citas: 9
• Garcia-Carrasco M. et al. : Vitamin D and Sjögren syndrome : Autoimmunity Reviews 16 (6) . Pags. 587-593 (2017).
  DOI: 10.1016/j.autrev.2017.04.004
  Citas: 43
• García-Carrasco M. et al. : Vitamin D insufficiency and deficiency in mexican patients with systemic lupus erythematosus: Prevalence and relationship with disease activity : Reumatologia Clinica 13 (2) . Pags. 97-101 (2017).
  DOI: 10.1016/j.reuma.2016.02.013
  Citas: 15
• Etchegaray-Morales I. et al. : Factors associated with health-related quality of life in Mexican lupus patients using the LupusQoL : Plos One 12 (1) (2017).
  DOI: 10.1371/journal.pone.0170209
  Citas: 36
• Rosas J. et al. : Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis : Clinical and Experimental Rheumatology 35 (1) . Pags. 145-148 (2017).

2016

• García-Carrasco M. et al. : Serum levels of vitamin D in systemic lupus erythematosus patients (SLE) and their relationship with disease activity: Longitudinal study : Gaceta Medica De Mexico 152 . Pags. 32-37 (2016).
• García-Carrasco M. et al. : Vitamin D and cardiovascular disease in patients with systemic lupus erythematosus : Reumatologia Clinica 12 (5) . Pags. 241-243 (2016).
  DOI: 10.1016/j.reuma.2016.07.006
  Citas: 3
• Méndez-Martínez S. et al. : Surgical complications of simple and complex gastroschisis in newborn : European Journal of General Medicine 13 (2) . Pags. 88-93 (2016).
  DOI: 10.15197/ejgm.1495
  Citas: 9

2015

• García-Carrasco M. et al. : Vitamin D and autoimmune rheumatic disease : Reumatologia Clinica 11 (6) . Pags. 333-334 (2015).
  DOI: 10.1016/j.reuma.2015.11.001
  Citas: 12
• Garcia-Carrasco M. et al. : The role of infectious diseases in the catastrophic antiphospholipid syndrome : Autoimmunity Reviews 14 (11) . Pags. 1066-1071 (2015).
  DOI: 10.1016/j.autrev.2015.07.009
  Citas: 27
• Mendoza-Pinto C. et al. : Socioeconomic status and organ damage in Mexican systemic lupus erythematosus women : Lupus 24 (11) . Pags. 1227-1232 (2015).
  DOI: 10.1177/0961203315591621
  Citas: 14
• García-Carrasco M. et al. : P-glycoprotein in autoimmune rheumatic diseases : Autoimmunity Reviews 14 (7) . Pags. 594-600 (2015).
  DOI: 10.1016/j.autrev.2015.02.006
  Citas: 40
• García-Carrasco M. et al. : Lack of association between serum 25-hydroxyvitamin D levels and cervical human papillomavirus infection in systemic lupus erythematosus : Lupus 24 (6) . Pags. 606-612 (2015).
  DOI: 10.1177/0961203314559628
  Citas: 20
• De Jesus G.R. et al. : Understanding and Managing Pregnancy in Patients with Lupus : Autoimmune Diseases 2015 (2015).
  DOI: 10.1155/2015/943490
  Citas: 64
• Mendoza-Pinto C. et al. : Carotid atherosclerosis is not associated with lower bone mineral density and vertebral fractures in patients with systemic lupus erythematosus : Lupus 24 (1) . Pags. 25-31 (2015).
  DOI: 10.1177/0961203314548247
  Citas: 7
• Tamborenea M.N. et al. : Work instability in rheumatoid arthritis patients from Argentina: Prevalence and associated factors : Rheumatology International 35 (1) . Pags. 107-114 (2015).
  DOI: 10.1007/s00296-014-3062-7
  Citas: 6

2014

• Salvatori-Rubí J. et al. : Cervical arthrodesis by means of interbody fusion with autologous bone and/or interbody spacer for cervical disc disease : Acta Ortopedica Mexicana 28 (5) . Pags. 273-276 (2014).
• García-Stivalet L. et al. : Clinical analysis of 200 cases of idiopathic thrombocytopenic purpura : Revista Medica Del Instituto Mexicano Del Seguro Social 52 (3) . Pags. 322-325 (2014).
• Salvatori-Rubí J. et al. : Total knee replacement due to grade IV gonarthrosis : Acta Ortopedica Mexicana 28 (3) . Pags. 193-196 (2014).
• García-Carrasco M. et al. : Diagnosis and classification of Susac syndrome : Autoimmunity Reviews 13 (4-5) . Pags. 347-350 (2014).
  DOI: 10.1016/j.autrev.2014.01.038
  Citas: 66
• García-Galicia A. et al. : Validity and consistency of the ECAVIPEP and CAVE scales to assess quality of life in paediatric patients with epilepsy : Revista De Neurologia 59 (7) . Pags. 301-306 (2014).
  DOI: 10.33588/rn.5907.2014241
  Citas: 5
• Barragán-Hervella et al. : Results of surgical management in proximal partial tibia fractures : Acta Ortopedica Mexicana 28 (1) . Pags. 39-44 (2014).
• Garcia-Carrasco M. et al. : Thyroid disorders, hyperprolactinemia and systemic lupus erythematosus activity : International Journal of Clinical Rheumatology 9 (5) . Pags. 441-447 (2014).
  DOI: 10.2217/ijr.14.36
  Citas: 1
• Rosas J. et al. : Clinical relevance of monitoring serum levels of adalimumab in patients with rheumatoid arthritis in daily practice : Clinical and Experimental Rheumatology 32 (6) . Pags. 942-948 (2014).

2013

• García Carrasco M. et al. : Irritable bowel syndrome-type symptoms in female patients with mild systemic lupus erythematosus: Frequency, related factors and quality of life : Neurogastroenterology and Motility 25 (12) . Pags. 958-966 (2013).
  DOI: 10.1111/nmo.12230
  Citas: 12
• Mendoza-Pinto C. et al. : The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus : Clinics 68 (12) . Pags. 1475-1480 (2013).
  DOI: 10.6061/clinics/2013(12)01
  Citas: 13
• Fuentes-Alexandro S. et al. : Transcatheter Aortic Valve Replacement (TAVR) in patients with systemic autoimmune diseases : Lupus 22 (13) . Pags. 1433-1434 (2013).
  DOI: 10.1177/0961203313504147
  Citas: 5
• Ruiz-Argüelles A. et al. : Treatment of vitiligo with a chimeric monoclonal antibody to CD20: A pilot study : Clinical and Experimental Immunology 174 (2) . Pags. 229-236 (2013).
  DOI: 10.1111/cei.12168
  Citas: 20
• Pinto C. et al. : Bone mineral density in systemic lupus erythematosus women one year after rituximab therapy : Lupus 22 (11) . Pags. 1128-1134 (2013).
  DOI: 10.1177/0961203313502861
  Citas: 4
• Soto-Vega E. et al. : Antiphospholipid antibodies in Mexican HIV-positive patients : Inmunologia 32 (1) . Pags. 12-16 (2013).
  DOI: 10.1016/j.inmuno.2012.10.002
  Citas: 1

2012

• García-Carrasco M. et al. : Serologic features of primary Sjögren's syndrome: Clinical and prognostic correlation : International Journal of Clinical Rheumatology 7 (6) . Pags. 651-659 (2012).
  DOI: 10.2217/ijr.12.64
  Citas: 34
• Anaya J. et al. : The autoimmune tautology: From polyautoimmunity and familial autoimmunity to the autoimmune genes : Autoimmune Diseases 1 (1) (2012).
  DOI: 10.1155/2012/297193
  Citas: 29
• Zamora-Ustaran A. et al. : Antiphospholipid syndrome in Mexican children : Israel Medical Association Journal 14 (5) . Pags. 286-289 (2012).
• Montiel-Jarquín A. et al. : Lactate clearance is a prognostic factor in patients on shock state : European Journal of General Medicine 9 (2) . Pags. 98-103 (2012).
  DOI: 10.29333/ejgm/82472
  Citas: 4
• García-Carrasco M. et al. : Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C). : Lupus 21 (11) . Pags. 1219-1224 (2012).
  DOI: 10.1177/0961203312456749
  Citas: 31

2011

• Sandoval-Cruz M. et al. : Immunopathogenesis of vitiligo : Autoimmunity Reviews 10 (12) . Pags. 762-765 (2011).
  DOI: 10.1016/j.autrev.2011.02.004
  Citas: 130
• García-Carrasco M. et al. : Susac's syndrome: An update : Autoimmunity Reviews 10 (9) . Pags. 548-552 (2011).
  DOI: 10.1016/j.autrev.2011.04.006
  Citas: 28
• García-Carrasco M. et al. : Influence of prevalent vertebral fractures on the quality of life of patients with systemic lupus erythematosus : Israel Medical Association Journal 13 (6) . Pags. 333-337 (2011).

2010

• Vera-Recabarren M.A. et al. : Cutaneous lupus erythematosus: Clinical and immunological study of 308 patients stratified by gender : Clinical and Experimental Dermatology 35 (7) . Pags. 729-735 (2010).
  DOI: 10.1111/j.1365-2230.2009.03764.x
  Citas: 25
• Escárcega R.O. et al. : Transradial percutaneous coronary intervention without on-site cardiac surgery for stable coronary disease and myocardial infarction: Preliminary report and initial experience in 174 patients : Israel Medical Association Journal 12 (10) . Pags. 592-597 (2010).
• López-Colombo A. et al. : Torsion of the omentum. A rare cause of acute abdomen. : Revista Medica Del Instituto Mexicano Del Seguro Social 48 (5) . Pags. 549-552 (2010).
• Escárcega R. et al. : Supraventricular tachyarrhythmia and Brugada syndrome: a case of atrial fibrillation and Brugada syndrome in a young patient without structural heart disease. : West Indian Medical Journal 59 (2) . Pags. 222-225 (2010).
• Garcia-Carrasco M. et al. : Anti-CD20 therapy in patients with refractory systemic lupus erythematosus: A longitudinal analysis of 52 Hispanic patients : Lupus 19 (2) . Pags. 213-219 (2010).
  DOI: 10.1177/0961203309351541
  Citas: 75
• Vera-Recabarren M.A. et al. : Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: Clinical and immunological study of 270 patients : British Journal of Dermatology 162 (1) . Pags. 91-101 (2010).
  DOI: 10.1111/j.1365-2133.2009.09472.x
  Citas: 97
• Mendoza-Pinto C. et al. : Etiopathogenesis of Behcet's disease : Autoimmunity Reviews 9 (4) . Pags. 241-245 (2010).
  DOI: 10.1016/j.autrev.2009.10.005
  Citas: 152

2009

• Escárcega R.O. et al. : The Brugada syndrome : Acta Cardiologica 64 (6) . Pags. 795-801 (2009).
  DOI: 10.2143/AC.64.6.2044745
  Citas: 10
• García-Carrasco M. et al. : Osteoporosis in patients with systemic lupus erythematosus : Israel Medical Association Journal 11 (8) . Pags. 486-491 (2009).
• Soto-Vega E. et al. : P-glycoprotein activity in renal clear cell carcinoma : Urologic Oncology Seminars and Original Investigations 27 (4) . Pags. 363-366 (2009).
  DOI: 10.1016/j.urolonc.2008.01.011
  Citas: 14
• García-Carrasco M. et al. : Infections and the antiphospholipid syndrome : Clinical Reviews in Allergy and Immunology 36 (2-3) . Pags. 104-108 (2009).
  DOI: 10.1007/s12016-008-8103-0
  Citas: 32
• Nava A. et al. : On the musculoskeletal involvement in patients with brucellosis from an endemic area : Gazzetta Medica Italiana Archivio Per Le Scienze Mediche 168 (3) . Pags. 143-147 (2009).
• Escárcega R.O. et al. : Accelerated atherosclerosis in systemic lupus erythematosus: Perspectives towards decreasing cardiovascular morbidity and mortality : Lupus 18 (5) . Pags. 383-386 (2009).
  DOI: 10.1177/0961203308101435
  Citas: 13
• Mendoza-Pinto C. et al. : Risk factors of vertebral fractures in women with systemic lupus erythematosus : Clinical Rheumatology 28 (5) . Pags. 579-585 (2009).
  DOI: 10.1007/s10067-009-1105-3
  Citas: 49
• García-Carrasco M. et al. : Use of rituximab in patients with systemic lupus erythematosus: An update : Autoimmunity Reviews 8 (4) . Pags. 343-348 (2009).
  DOI: 10.1016/j.autrev.2008.11.006
  Citas: 62
• Mendoza-Pinto C. et al. : Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus : Clinical Rheumatology 28 (1) . Pags. 65-70 (2009).
  DOI: 10.1007/s10067-008-0984-z
  Citas: 33

2008

• Ruiz-Argüelles A. et al. : Chapter 7 Thyroid Dysfunction and the Immune System : Handbook of Systemic Autoimmune Diseases 9 . Pags. 75-80 (2008).
  DOI: 10.1016/S1571-5078(07)00207-3
  Citas: 1
• García-Carrasco M. et al. : Treatment of Raynaud's phenomenon : Autoimmunity Reviews 8 (1) . Pags. 62-68 (2008).
  DOI: 10.1016/j.autrev.2008.07.002
  Citas: 37
• Mejía-Romero R. et al. : Primary antiphospholipid syndrome in Latin American mestizo patients: Clinical and immunologic characteristics and comparison with European patients : Clinical Rheumatology 27 (7) . Pags. 891-897 (2008).
  DOI: 10.1007/s10067-007-0818-4
  Citas: 21

2007

• Pérez-Chávez G. et al. : Splenic hemangioma : Gaceta Medica De Mexico 143 (6) . Pags. 523-524 (2007).
• García-Carrasco M. et al. : Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis{lozenge, open}{lozenge, open}Pour citer cet article, utiliser ce titre en anglais et sa référence dans le même volume de Joint Bone Spine. : Revue Du Rhumatisme Edition Francaise 74 (9) . Pags. 905-908 (2007).
  DOI: 10.1016/j.rhum.2007.06.002
  Citas: 0
• García-Carrasco M. et al. : Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis : Joint Bone Spine 74 (5) . Pags. 500-503 (2007).
  DOI: 10.1016/j.jbspin.2006.12.004
  Citas: 34
• Jara L.J. et al. : Thyroid disease in Sjögren's syndrome : Clinical Rheumatology 26 (10) . Pags. 1601-1606 (2007).
  DOI: 10.1007/s10067-007-0638-6
  Citas: 96
• Rojas-Rodríguez J. et al. : The relationship between the metabolic syndrome and energy-utilization deficit in the pathogenesis of obesity-induced osteoarthritis : Medical Hypotheses 69 (4) . Pags. 860-868 (2007).
  DOI: 10.1016/j.mehy.2007.01.075
  Citas: 41
• Garciá-Carrasco M. et al. : Preventing death in the catastrophic antiphospholipid (Asherson) syndrome : Israel Medical Association Journal 9 (8) . Pags. 628-629 (2007).
• García-Carrasco M. et al. : Antiphospholipid syndrome in Latin American patients: Clinical and immunologic characteristics and comparison with European patients : Lupus 16 (5) . Pags. 366-373 (2007).
  DOI: 10.1177/0961203307077108
  Citas: 44
• García-Carrasco M. et al. : Therapeutic options in autoimmune myasthenia gravis : Autoimmunity Reviews 6 (6) . Pags. 373-378 (2007).
  DOI: 10.1016/j.autrev.2007.01.001
  Citas: 51
• Gómez-Puerta J.A. et al. : Catastrophic antiphospholipid syndrome during pregnancy and puerperium: Maternal and fetal characteristics of 15 cases : Annals of the Rheumatic Diseases 66 (6) . Pags. 740-746 (2007).
  DOI: 10.1136/ard.2006.061671
  Citas: 94
• García-Carrasco M. et al. : Lack of subclinical myocardial ischaemia in Mexican patients with systemic lupus erythematosus without traditional risk factors for coronary artery disease : Lupus 16 (4) . Pags. 298-301 (2007).
  DOI: 10.1177/0961203307076519
  Citas: 5
• García-Carrasco M. et al. : Systemic juvenile rheumatoid arthritis : Revista Medica Del Instituto Mexicano Del Seguro Social 45 (2) . Pags. 187-189 (2007).
• Escárcega R. et al. : The Transcription Factor Nuclear Factor-kappa B and Cancer : Clinical Oncology 19 (2) . Pags. 154-161 (2007).
  DOI: 10.1016/j.clon.2006.11.013
  Citas: 215

2006

• García-Carrasco M. et al. : Pathophysiology of Sjögren's Syndrome : Archives of Medical Research 37 (8) . Pags. 921-932 (2006).
  DOI: 10.1016/j.arcmed.2006.08.002
  Citas: 94
• Escárcega R.O. et al. : Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease : Autoimmunity Reviews 6 (1) . Pags. 48-53 (2006).
  DOI: 10.1016/j.autrev.2006.07.001
  Citas: 48
• Cervera R. et al. : Systemic lupus erythematosus in Europe at the change of the millennium: Lessons from the "Euro-Lupus Project" : Autoimmunity Reviews 5 (3) . Pags. 180-186 (2006).
  DOI: 10.1016/j.autrev.2005.06.004
  Citas: 118
• García-Carrasco M. et al. : Extrahepatic autoimmune manifestations of chronic hepatitis C virus infection : Annals of Hepatology 5 (3) . Pags. 161-163 (2006).
  DOI: 10.1016/s1665-2681(19)32000-9
  Citas: 4

2004

• Espinosa G. et al. : Pulmonary Involvement in the Antiphospholipid Syndrome : Handbook of Systemic Autoimmune Diseases 2 . Pags. 137-145 (2004).
  DOI: 10.1016/S1571-5078(04)02007-0
  Citas: 2
• Cervera R. et al. : Antiphospholipid syndrome associated with infections: Clinical and microbiological characteristics of 100 patients : Annals of the Rheumatic Diseases 63 (10) . Pags. 1312-1317 (2004).
  DOI: 10.1136/ard.2003.014175
  Citas: 182
• Ramos-Casals M. et al. : Interleukin-4 receptor α polymorphisms in primary Sj∨gren syndrome [1] : Clinical and Experimental Rheumatology 22 (3) . Pags. 374 (2004).
• Ramos-Casals M. et al. : Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): Description of 82 cases : Clinical Infectious Diseases 38 (7) . Pags. 1009-1016 (2004).
  DOI: 10.1086/382537
  Citas: 74
• Ramos-Casals M. et al. : Sarcoidosis or Sjögren Syndrome? Clues to Defining Mimicry or Coexistence in 59 Cases : Medicine 83 (2) . Pags. 85-95 (2004).
  DOI: 10.1097/01.md.0000121237.98962.1e
  Citas: 80
• Ramos-Casals M. et al. : Cutaneous Vasculitis in Primary Sjögren Syndrome: Classification and Clinical Significance of 52 Patients : Medicine 83 (2) . Pags. 96-106 (2004).
  DOI: 10.1097/01.md.0000119465.24818.98
  Citas: 186
• Ramos-Casals M. et al. : Triple Association between Hepatitis C Virus Infection, Systemic Autoimmune Diseases, and B Cell Lymphoma : Journal of Rheumatology 31 (3) . Pags. 495-499 (2004).
• Font J. et al. : Clusters of Clinical and Immunologic Features in Systemic Lupus Erythematosus: Analysis of 600 Patients from a Single Center : Seminars in Arthritis and Rheumatism 33 (4) . Pags. 217-230 (2004).
  DOI: 10.1053/S0049-0172(03)00133-1
  Citas: 145

2003

• Ramos-Casals M. et al. : Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection : Rheumatology 42 (7) . Pags. 818-828 (2003).
  DOI: 10.1093/rheumatology/keg299
  Citas: 48
• Font J. et al. : Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature : Journal of Rheumatology 30 (7) . Pags. 1552-1557 (2003).
• Ramos-Casals M. et al. : Autoimmunity and geriatrics: Clinical significance of autoimmune manifestations in the elderly : Lupus 12 (5) . Pags. 341-355 (2003).
  DOI: 10.1191/0961203303lu383ed
  Citas: 127
• Suárez Ortega S. et al. : Manifestations of liver disease caused by hepatitis C virus (multiple letters [1] : Revista Clinica Espanola 203 (5) . Pags. 263 (2003).
  DOI: 10.1016/s0014-2565(03)71259-4
  Citas: 0
• Cervera R. et al. : Anti-chromatin antibodies in systemic lupus erythematosus: A useful marker for lupus nephropathy : Annals of the Rheumatic Diseases 62 (5) . Pags. 431-434 (2003).
  DOI: 10.1136/ard.62.5.431
  Citas: 105
• Ramos-Casals M. et al. : Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection clinical description of 35 cases : Medicine 82 (2) . Pags. 87-96 (2003).
  DOI: 10.1097/00005792-200303000-00003
  Citas: 103
• Ramos-Casals M. et al. : Sjögren's syndrome, hepatitis C virus and B-cell lymphoproliferation. Common immunopathogenic mechanisms : Inmunologia 22 (1) . Pags. 63-73 (2003).
• Ramos-Casals M. et al. : Sjögren's syndrome and lymphoproliferative disease: A possible relationship mediated by viral agents : Clinical Application of Immunology 2 (1) . Pags. 141-152 (2003).
• Trejo O. et al. : Hematologic malignancies in patients with cryoglobulinemia: Association with autoimmune and chronic viral diseases : Seminars in Arthritis and Rheumatism 33 (1) . Pags. 19-28 (2003).
  DOI: 10.1053/sarh.2003.50020
  Citas: 45
• Miret C. et al. : Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity : Tumor Biology 24 (4) . Pags. 185-188 (2003).
  DOI: 10.1159/000074428
  Citas: 24

2002

• Font J. et al. : Low values of creatine kinase in systemic lupus erythematosus. Clinical significance in 300 patients : Clinical and Experimental Rheumatology 20 (6) . Pags. 837-840 (2002).
• Font J. et al. : The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome : Rheumatology 41 (9) . Pags. 1025-1030 (2002).
• Ramos-Casals M. et al. : Viral etiopathogenesis of Sjögren's syndrome: Role of the hepatitis C virus : Autoimmunity Reviews 1 (4) . Pags. 238-243 (2002).
  DOI: 10.1016/S1568-9972(02)00057-5
  Citas: 40
• García-Carrasco M. et al. : Primary Sjögren syndrome: Clinical and immunologic disease patterns in a cohort of 400 patients : Medicine 81 (4) . Pags. 270-280 (2002).
  DOI: 10.1097/00005792-200207000-00003
  Citas: 366
• Ramos-Casals M. et al. : Primary Sjögren syndrome: Hematologic patterns of disease expression : Medicine 81 (4) . Pags. 281-292 (2002).
  DOI: 10.1097/00005792-200207000-00004
  Citas: 142
• Rosas J. et al. : Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features : Rheumatology 41 (6) . Pags. 670-675 (2002).
• García-Carrasco M. et al. : Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients : Journal of Rheumatology 29 (4) . Pags. 726-730 (2002).
• Ramos-Casals M. et al. : Th1/Th2 cytokine imbalance in patients with Sjögren syndrome secondary to hepatitis C virus infection : Seminars in Arthritis and Rheumatism 32 (1) . Pags. 56-63 (2002).
  DOI: 10.1053/sarh.2002.33724
  Citas: 33

2001

• Miret C. et al. : Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus : Anticancer Research 21 (4 B) . Pags. 3053-3059 (2001).
• García-Carrasco M. et al. : El virus de la hepatitis C en el lupus eritematoso sistémico y el síndrome antifosfolipídico : Revista Espanola De Reumatologia 28 (8) . Pags. 330-340 (2001).
• Trejo O. et al. : Cryoglobulinemia: Study of etiologic factors and clinical and immunologic features in 443 patients from a single center : Medicine 80 (4) . Pags. 252-262 (2001).
  DOI: 10.1097/00005792-200107000-00004
  Citas: 279
• García-Carrasco M. et al. : Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: Correlation with clinical and immunological features : Clinical and Experimental Rheumatology 19 (4) . Pags. 411-415 (2001).
• Ramos-Casals M. et al. : Hepatitis C virus infection mimicking primary Sjögren syndrome: A clinical and immunologic description of 35 cases : Medicine 80 (1) . Pags. 1-8 (2001).
  DOI: 10.1097/00005792-200101000-00001
  Citas: 160
• García-Carrasco M. et al. : Cryoglobulins : Vascular Manifestations of Systemic Autoimmune Diseases . Pags. 119-136 (2001).
• Ramos-Casals M. et al. : Is hepatitis C virus a sialotropic virus? : American Journal of Pathology 159 (4) . Pags. 1593-1594 (2001).
  DOI: 10.1016/S0002-9440(10)62543-6
  Citas: 31
• García-Carrasco M. et al. : Cryoglobulinemia in systemic lupus erythematosus: Prevalence and clinical characteristics in a series of 122 patients : Seminars in Arthritis and Rheumatism 30 (5) . Pags. 366-373 (2001).
  DOI: 10.1053/sarh.2001.20265
  Citas: 81
• Ramos-Casals M. et al. : High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome : Rheumatology 40 (9) . Pags. 1056-1059 (2001).
  DOI: 10.1093/rheumatology/40.9.1056
  Citas: 45
• Asherson R.A. et al. : Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients : Medicine 80 (6) . Pags. 355-377 (2001).
  DOI: 10.1097/00005792-200111000-00002
  Citas: 357
• Font J. et al. : Cardiovascular risk factors and the long-term outcome of lupus nephritis : QJM an International Journal of Medicine 94 (1) . Pags. 19-26 (2001).
  DOI: 10.1093/qjmed/94.1.19
  Citas: 72

2000

• Font J. et al. : Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE) : Clinical and Experimental Immunology 119 (1) . Pags. 169-174 (2000).
  DOI: 10.1046/j.1365-2249.2000.01082.x
  Citas: 28
• Cervera R. et al. : Primary Sjogren's syndrome in men: Clinical and immunological characteristics : Lupus 9 (1) . Pags. 61-64 (2000).
  DOI: 10.1177/096120330000900111
  Citas: 40
• Ramos-Casals M. et al. : Cytopenia and past human parvovirus B19 infection in patients with primary Sjogren's syndrome : Seminars in Arthritis and Rheumatism 29 (6) . Pags. 373-378 (2000).
  DOI: 10.1053/sarh.2000.7024
  Citas: 35
• Segui J. et al. : Psychiatric and psychosocial disorders in patients with systematic lupus erythematosus: A longitudinal study of active and inactive stages of the disease : Lupus 9 (8) . Pags. 584-588 (2000).
  DOI: 10.1191/096120300678828730
  Citas: 71
• Ramos-Casals M. et al. : Mixed cryoglobulinemia: New concepts : Lupus 9 (2) . Pags. 83-91 (2000).
  DOI: 10.1191/096120300678828127
  Citas: 85
• Rojas-Rodriguez J. et al. : Catastrophic antiphospholipid syndrome: Clinical description and triggering factors in 8 patients : Journal of Rheumatology 27 (1) . Pags. 238-240 (2000).
• Ramos-Casals M. et al. : Thyroid disease in primary Sjogren syndrome: Study in a series of 160 patients : Medicine 79 (2) . Pags. 103-108 (2000).
  DOI: 10.1097/00005792-200003000-00004
  Citas: 86
• García-Carrasco M. et al. : Síndrome de Sjögren primario y linfoproliferación : Medicina Clinica 114 (19) . Pags. 740-746 (2000).
  DOI: 10.1016/S0025-7753(00)71420-5
  Citas: 11
• García-Carrasco M. et al. : Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjogren's syndrome : Annals of the Rheumatic Diseases 59 (4) . Pags. 297-299 (2000).
  DOI: 10.1136/ard.59.4.297
  Citas: 11
• Font J. et al. : Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: Report of two cases : Annals of the Rheumatic Diseases 59 (11) . Pags. 920-923 (2000).
  DOI: 10.1136/ard.59.11.920
  Citas: 25
• Ramos-Casals M. et al. : Hepatitis C virus infection mimicking systemic lupus erythematosus: Study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus : Arthritis and Rheumatism 43 (12) . Pags. 2801-2806 (2000).
  DOI: 10.1002/1529-0131(200012)43:12<2801::AID-ANR21>3.0.CO;2-V
  Citas: 102
• García-Carrasco M. et al. : El tratamiento del fenómeno de Raynaud : Revista Espanola De Reumatologia 27 (7) . Pags. 322-327 (2000).

1999

• García-Carrasco M. et al. : Primary Sjogren's syndrome in the elderly: Clinical and immunological characteristics : Lupus 8 (1) . Pags. 20-23 (1999).
  DOI: 10.1191/096120399678847353
  Citas: 67
• Montehermoso A. et al. : Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus : Seminars in Arthritis and Rheumatism 28 (5) . Pags. 326-332 (1999).
  DOI: 10.1016/S0049-0172(99)80017-1
  Citas: 80
• Morlà R.M. et al. : Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: Report of two cases and review of the literature : Lupus 8 (2) . Pags. 160-163 (1999).
  DOI: 10.1191/096120399678847515
  Citas: 47
• Pérez-Cuevas J.B. et al. : A quality of life study in women with systemic lupus erythematosus and its relation to disease activity : Anales De Medicina Interna Madrid Spain 1984 16 (9) . Pags. 457-460 (1999).
• Ramos-Casals M. et al. : Sjogren's syndrome and hepatitis C virus : Clinical Rheumatology 18 (2) . Pags. 93-100 (1999).
  DOI: 10.1007/s100670050064
  Citas: 66
• Casals M. et al. : Sjögren syndrome and hepatitis C virus infection : Medicina Clinica 112 (18) . Pags. 718-719 (1999).
• Blanco Y. et al. : Síndrome antifosfolipídico primario que evoluciona a lupus eritematoso sistémico: Presentación de tres nuevos casos y revisión de la literatura : Revista Clinica Espanola 199 (9) . Pags. 586-588 (1999).
• Miret C. et al. : Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity : Anticancer Research 19 (4 B) . Pags. 3073-3076 (1999).
• Ramos-Casals M. et al. : Sjogren and virus syndrome : Revista Espanola De Reumatologia 26 (8) . Pags. 310-317 (1999).

1998

• Ramos-Casals M. et al. : Cryoglobulinemia in primary Sjogren's syndrome: Prevalence and clinical characteristics in a series of 115 patients : Seminars in Arthritis and Rheumatism 28 (3) . Pags. 200-205 (1998).
  DOI: 10.1016/S0049-0172(98)80037-1
  Citas: 114
• Font J. et al. : Hepatitis G virus infection in primary Sjogren's syndrome: Analysis in a series of 100 patients : Annals of the Rheumatic Diseases 57 (1) . Pags. 42-44 (1998).
  DOI: 10.1136/ard.57.1.42
  Citas: 22
• Font J. et al. : Systemic lupus erythematosus (SLE) in childhood: Analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults : Annals of the Rheumatic Diseases 57 (8) . Pags. 456-459 (1998).
  DOI: 10.1136/ard.57.8.456
  Citas: 234
• Ramos-Casals M. et al. : Young onset of primary Sjogren's syndrome: Clinical and immunological characteristics : Lupus 7 (3) . Pags. 202-206 (1998).
  DOI: 10.1191/096120398678920019
  Citas: 94
• Rojas-Rodriguez J. et al. : Optic neuropathy in a child with primary Sjogren's syndrome : Revue Du Rhumatisme English Edition 65 (5) . Pags. 355-357 (1998).
• Font J. et al. : Antineutrophil cytoplasmic antibodies in primary Sjogren's syndrome: Prevalence and clinical significance : British Journal of Rheumatology 37 (12) . Pags. 1287-1291 (1998).

1997

• Miret C. et al. : Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: Transient 'seronegative' antiphospholipid syndrome? : Clinical and Experimental Rheumatology 15 (5) . Pags. 541-544 (1997).
• García-Carrasco M. et al. : Sjogren syndrome and infection by the virus C : Revista Espanola De Reumatologia 24 (7) . Pags. 220-225 (1997).
• Cervera R. et al. : Antiphospholipid antibodies in primary Sjogren's syndrome: Prevalence and clinical significance in a series of 80 patients : Clinical and Experimental Rheumatology 15 (4) . Pags. 361-365 (1997).
• Ramos M. et al. : Primary Sjögren's syndrome: Clinical and immunologic study of 80 patients : Medicina Clinica 108 (17) . Pags. 652-657 (1997).
• Garcia-Carrasco M. et al. : Hepatitis C virus infection in 'primary' Sjogren's syndrome: Prevalence and clinical significance in a series of 90 patients : Annals of the Rheumatic Diseases 56 (3) . Pags. 173-175 (1997).
  DOI: 10.1136/ard.56.3.173
  Citas: 91

1996

• Miro O. et al. : Muscle involvement in rheumatoid arthritis: Clinicopathological study of 21 symptomatic cases : Seminars in Arthritis and Rheumatism 25 (6) . Pags. 421-428 (1996).
  DOI: 10.1016/S0049-0172(96)80007-2
  Citas: 60

1995

• Miró O. et al. : A comparative study of the clinical and histological characteristics between classic nemaline myopathy and that associated with the human immunodeficiency virus : Medicina Clinica 105 (13) . Pags. 500-503 (1995).